265 related articles for article (PubMed ID: 24135280)
1. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
Fan QW; Cheng CK; Gustafson WC; Charron E; Zipper P; Wong RA; Chen J; Lau J; Knobbe-Thomsen C; Weller M; Jura N; Reifenberger G; Shokat KM; Weiss WA
Cancer Cell; 2013 Oct; 24(4):438-49. PubMed ID: 24135280
[TBL] [Abstract][Full Text] [Related]
2. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
[TBL] [Abstract][Full Text] [Related]
3. EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.
Yeo AT; Jun HJ; Appleman VA; Zhang P; Varma H; Sarkaria JN; Charest A
Oncogene; 2021 Apr; 40(15):2682-2696. PubMed ID: 33707748
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional control of brain tumor stem cells by a carbohydrate binding protein.
Sharanek A; Burban A; Hernandez-Corchado A; Madrigal A; Fatakdawala I; Najafabadi HS; Soleimani VD; Jahani-Asl A
Cell Rep; 2021 Aug; 36(9):109647. PubMed ID: 34469737
[TBL] [Abstract][Full Text] [Related]
5. A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5.
Huang W; Li J; Zhu H; Qin X; Chen C; Wang B; Wei J; Song Y; Lu X; Li Z; Xia W; He A; Cheng L; Yu X; Shu K; Wang W
Neuro Oncol; 2024 Jan; 26(1):85-99. PubMed ID: 37616578
[TBL] [Abstract][Full Text] [Related]
6. Targeting OSMR in glioma stem cells.
Mohan S; Bonni A; Jahani-Asl A
Oncotarget; 2017 Mar; 8(10):16103-16104. PubMed ID: 28177884
[No Abstract] [Full Text] [Related]
7. Temozolomide Induces Endocytosis of EGFRvIII via p38-Mediated Non-canonical Phosphorylation in Glioblastoma Cells.
Haryuni RD; Tanaka T; Takahashi JI; Onuma I; Zhou Y; Yokoyama S; Sakurai H
Biol Pharm Bull; 2021; 44(11):1681-1687. PubMed ID: 34719645
[TBL] [Abstract][Full Text] [Related]
8. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
9. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition.
Jutten B; Keulers TG; Peeters HJM; Schaaf MBE; Savelkouls KGM; Compter I; Clarijs R; Schijns OEMG; Ackermans L; Teernstra OPM; Zonneveld MI; Colaris RME; Dubois L; Vooijs MA; Bussink J; Sotelo J; Theys J; Lammering G; Rouschop KMA
Autophagy; 2018; 14(2):283-295. PubMed ID: 29377763
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
Yin J; Seo Y; Rhim J; Jin X; Kim TH; Kim SS; Hong JH; Gwak HS; Yoo H; Park JB; Kim JH
Cancer Res; 2023 Nov; 83(22):3693-3709. PubMed ID: 37747775
[TBL] [Abstract][Full Text] [Related]
11. GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.
Choi J; Bordeaux ZA; McKeel J; Nanni C; Sutaria N; Braun G; Davis C; Miller MN; Alphonse MP; Kwatra SG; West CE; Kwatra MM
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456993
[TBL] [Abstract][Full Text] [Related]
12. The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
Hoogstrate Y; Ghisai SA; de Wit M; de Heer I; Draaisma K; van Riet J; van de Werken HJG; Bours V; Buter J; Vanden Bempt I; Eoli M; Franceschi E; Frenel JS; Gorlia T; Hanse MC; Hoeben A; Kerkhof M; Kros JM; Leenstra S; Lombardi G; Lukacova S; Robe PA; Sepulveda JM; Taal W; Taphoorn M; Vernhout RM; Walenkamp AME; Watts C; Weller M; de Vos FYF; Jenster GW; van den Bent M; French PJ
Neuro Oncol; 2022 Mar; 24(3):429-441. PubMed ID: 34608482
[TBL] [Abstract][Full Text] [Related]
13. Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
Kenchappa RS; Dovas A; Argenziano MG; Meyer CT; Stopfer LE; Banu MA; Pereira B; Griffith J; Mohammad A; Talele S; Haddock A; Zarco N; Elmquist W; White F; Quaranta V; Sims P; Canoll P; Rosenfeld SS
Cell Rep; 2022 Jun; 39(12):110991. PubMed ID: 35732128
[TBL] [Abstract][Full Text] [Related]
14. The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification.
Schneider B; William D; Lamp N; Zimpfer A; Henker C; Classen CF; Erbersdobler A
Mol Cell Biochem; 2022 Sep; 477(9):2297-2307. PubMed ID: 35486213
[TBL] [Abstract][Full Text] [Related]
15. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
[TBL] [Abstract][Full Text] [Related]
16. EGFRvIII uses intrinsic and extrinsic mechanisms to reduce glioma adhesion and increase migration.
Banisadr A; Eick M; Beri P; Parisian AD; Yeoman B; Placone JK; Engler AJ; Furnari F
J Cell Sci; 2020 Dec; 133(24):. PubMed ID: 33243756
[TBL] [Abstract][Full Text] [Related]
17. STAT3 regulation of glioblastoma pathogenesis.
de la Iglesia N; Puram SV; Bonni A
Curr Mol Med; 2009 Jun; 9(5):580-90. PubMed ID: 19601808
[TBL] [Abstract][Full Text] [Related]
18. Poly(p-phenylenevinylene) nanoparticles modified with antiEGFRvIII for specific glioblastoma therapy.
Liang Y; Li Z; Yuan H; Wang L; Gao LH
Sci Rep; 2021 Feb; 11(1):4449. PubMed ID: 33627737
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides.
Mansour S; Adhya I; Lebleu C; Dumpati R; Rehan A; Chall S; Dai J; Errasti G; Delacroix T; Chakrabarti R
Sci Rep; 2022 Dec; 12(1):20725. PubMed ID: 36456600
[TBL] [Abstract][Full Text] [Related]
20. EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription.
Lu X; An L; Fan G; Zang L; Huang W; Li J; Liu J; Ge W; Huang Y; Xu J; Du S; Cao Y; Zhou T; Yin H; Yu L; Jiao S; Wang H
Cell Res; 2022 Apr; 32(4):359-374. PubMed ID: 35197608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
